Correction: Development of oligonucleotide-based antagonists of Ebola virus protein 24 inhibiting its interaction with karyopherin alpha 1

Keisuke Tanaka; Yuuya Kasahara; Yoichi Miyamoto; Takumi Okuda; Tatsuro Kasai; Kentaro Onodera; Masayasu Kuwahara; Masahiro Oka; Yoshihiro Yoneda; Satoshi Obika

doi:10.1039/C8OB90140F

Correction: Development of oligonucleotide-based antagonists of Ebola virus protein 24 inhibiting its interaction with karyopherin alpha 1

Keisuke Tanaka,^a Yuuya Kasahara,

*^ab Yoichi Miyamoto,^b Takumi Okuda,^a Tatsuro Kasai,^c Kentaro Onodera,^c Masayasu Kuwahara,

^cd Masahiro Oka,^b Yoshihiro Yoneda^b and Satoshi Obika

^ab

Author affiliations

* Corresponding authors

^a Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan

^b National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka 567-0085, Japan
E-mail: y-kasahara@nibiohn.go.jp

^c Graduate School of Science and Technology, Gunma University, Gunma 376-8515, Japan

^d Graduate School of Integrated Basic Sciences, Nihon University, Tokyo 156-8550, Japan

Abstract

Correction for ‘Development of oligonucleotide-based antagonists of Ebola virus protein 24 inhibiting its interaction with karyopherin alpha 1′ by Keisuke Tanaka et al., Org. Biomol. Chem., 2018, 16, 4456–4463.

Organic & Biomolecular Chemistry

Correction: Development of oligonucleotide-based antagonists of Ebola virus protein 24 inhibiting its interaction with karyopherin alpha 1

Abstract

Associated articles

Article information

Download Citation

Permissions

Correction: Development of oligonucleotide-based antagonists of Ebola virus protein 24 inhibiting its interaction with karyopherin alpha 1

Social activity

Search articles by author

Spotlight

Advertisements